Form 4: Semrush Holdings President Levin Exercises Options and Sells Shares
SEC Form 4 Filing
Eugenie Levin, President of Semrush Holdings, exercised stock options and sold shares of Class A Common Stock on May 8th and 9th, 2024, according to a Form 4 filing.
Summary
- On May 8th and 9th, 2024, Eugenie Levin, President of Semrush Holdings, executed multiple transactions involving the company's stock.
- Levin exercised options to acquire 276,136 shares of Class A Common Stock at $0 and $1.23.
- Concurrently, Levin sold 276,136 shares of Class A Common Stock at a weighted average price of $15.19 on May 8th and 36,483 shares at a weighted average price of $15.05 on May 9th.
- These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2023.
- Following these transactions, Levin directly owns 449,437 shares of Class A Common Stock and 1,210,800 Class B Common Stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document simply reports transactions. The use of a 10b5-1 plan suggests pre-planned sales, reducing the likelihood of a strong negative signal.
Industry Context
Insider transactions are common and closely monitored, providing insights into management's perspective on the company's valuation and future prospects. The use of a pre-arranged 10b5-1 trading plan suggests a planned and orderly approach to these transactions.
Comparison to Industry Standards
- Comparing Levin's transactions to those of executives at similar SaaS companies like HubSpot or Salesforce would provide context on the scale and frequency of insider trading.
- Reviewing filings from companies like Similarweb or Ahrefs, direct competitors of Semrush, could reveal similar patterns in executive compensation and stock transactions.
Stakeholder Impact
- The transactions could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price due to the increased supply of shares.
- Employees holding stock options may be interested in the executive's actions as a signal of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 05/12/2023 | Date of adoption of Rule 10b5-1 trading plan |
| 05/08/2024 | Date of stock option exercise and sale of shares |
| 05/09/2024 | Date of stock option exercise and sale of shares |
| 05/10/2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.